FDA Investigator Juliana M Badalucco
Juliana M Badalucco has conducted inspections on 6 sites in 1 countries as of 31 Oct 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
31 Oct 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Juliana M Badalucco:
Alice S Tsao,
Anastasia M Shields,
Bijoy Panicker,
Brandy N Lepage,
Bruce G Cooper,
Charanjeet Jassal,
Charisse K Green,
Dana A Razzano,
Daniel R Tammariello,
David M Mcnew,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Emest F Bizjak,
Gale L Glinecki,
Geoffrey K Wong,
George C Amedro,
Gladys B Casper,
James M Odonnell,
Jesse P Hardin,
Jonah S Ufferfilge,
Joseph J Vannelli,
Junho Pak,
Karishma G Gopaul,
Katelyn Astaub Zamperini,
Kenneth G Klobus,
Margaret E Sarles,
Merideth K Rose,
Michael W Burd,
Mindy M Chou,
Nebil A Oumer,
Nicholas C Mendiola,
Niketa Patel,
Paige R Mccoy,
Paul Mouris,
Richard K Glabach,
Roseline N Boateng,
Ruben C Quintana,
Russ E Davis,
Samina S Khan,
Sasha M Latonis,
Sayyem H Akbar,
Sena G Dissmeyer,
Shusheen A Alexander,
Sony Mathews,
Syeda N Mahazabin,
Tanya R Syffrard,
Vivin George,
Zakaria I Ganiyu
Juliana M Badalucco's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2022 | FDA 483 | Port Jervis Laboratories, Inc - Form 483, 2022-11-04 |
November, 2022 | EIR | Port Jervis Laboratories, Inc - EIR, 2022-11-04 |
June, 2022 | FDA 483 | GC HANFORD MFG CO - Form 483, 2022-06-17 |
November, 2022 | FDA 483 Response | Port Jervis Laboratories, Inc - Form 483R, 2022-11-23 |
December, 2021 | EIR | Aphena Pharma Solutions - Maryland, LLC - EIR, 2021-12-15 |
December, 2021 | FDA 483 | Aphena Pharma Solutions - Maryland, LLC - Form 483, 2021-12-15 |
November, 2021 | FDA 483 | Ultra Seal Corporation - Form 483, 2021-11-19 |
September, 2022 | FDA 483 | Scully's Wonderful Stuff Inc. - Form 483, 2022-09-15 |
March, 2022 | FDA 483 | Cosmed Group, Inc. - Form 483, 2022-03-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more